Research
Open Access
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trial
Vincent I. Lau, Robert Fowler, Ruxandra Pinto, Alain Tremblay, Sergio Borgia, François M. Carrier, Matthew P. Cheng, John Conly, Cecilia T. Costiniuk, Peter Daley, Erick Duan, Madeleine Durand, Patricia S. Fontela, George Farjou, Mike Fralick, Anna Geagea, Jennifer Grant, Yoav Keynan, Kosar Khwaja, Nelson Lee, Todd C. Lee, Rachel Lim, Conar R. O’Neil, Jesse Papenburg, Makeda Semret, Michael Silverman, Wendy Sligl, Ranjani Somayaji, Darrell H.S. Tan, Jennifer L.Y. Tsang, Jason Weatherald, Cedric Philippe Yansouni, Ryan Zarychanski and Srinivas Murthy; for the E-CATCO authors, AMMI Clinical Research Network and Canadian Critical Care Trials Group
September 06, 2022 10 (3) E807-E817; DOI: https://doi.org/10.9778/cmajo.20220077
Vincent I. Lau
Department of Critical Care Medicine (Lau, Sligl), Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton, Alta.; Interdepartmental Division of Critical Care Medicine (Fowler), University of Toronto; Department of Critical Care Medicine (Pinto), Sunnybrook Health Sciences Centre, Toronto, Ont.; Division of Respiratory Medicine (Tremblay, Lim, Weatherald), Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alta.; Division of Infectious Diseases (Borgia), William Osler Health System, Brampton, Ont.; Division of Infectious Diseases (Borgia), Department of Medicine, McMaster University, Hamilton, Ont.; Division of Critical Care Medicine (Carrier), Departments of Anesthesiology and Medicine, Centre hospitalier de l’Université de Montréal; Infectious Diseases and Medical Microbiology (Cheng), Department of Medicine, McGill University Health Centre, Montréal, Que.; Section of Infectious Diseases (Conly, Somayaji), Department of Medicine, Cumming School of Medicine, University of Calgary and Alberta Health Services, Calgary, Alta.; Division of Infectious Diseases and Chronic Viral Illness Service (Costiniuk), Department of Medicine, McGill University Health Centre, Montréal, Que.; Department of Medicine and Laboratory Medicine (Daley), Memorial University, St. John’s, NL; Division of Critical Care (Duan, Tsang), Department of Medicine, McMaster University, Hamilton, Ont.; Department of Medicine (Duan, Tsang), Niagara Health, St. Catharines, Ont.; Department of Critical Care (Duan), St. Joseph’s Healthcare, Hamilton, Ont.; Internal Medicine Service (Durand), Centre hospitalier de l’Université de Montréal; Division of Pediatric Critical Care (Fontela), Department of Pediatrics, McGill University, Montréal, Que.; Division of Infectious Disease (Farjou), Department of Medicine, Niagara Health, St. Catharines, Ont.; Department of Medicine (Fralick, Semret), Sinai Health, University of Toronto; Division of Critical Care Medicine (Geagea), Department of Medicine, North York General Hospital, Toronto, Ont.; Division of Medical Microbiology and Infectious Diseases (Grant), Department of Medicine, University of British Columbia, Vancouver, BC; Section of Infectious Diseases (Keynan), Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Departments of Surgery and Critical Care Medicine (Khwaja), McGill University, Montréal, Que.; Dalla Lana School of Public Health (N. Lee), University of Toronto, Toronto, Ont.; Clinical Practice Assessment Unit (T. Lee), Department of Medicine, McGill University, Montréal, Que.; Division of Infectious Diseases (O’Neil), Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta.; Division of Pediatric Infectious Diseases (Papenburg), Department of Pediatrics, Montreal Children’s Hospital; Division of Microbiology (Papenburg), Department of Clinical Laboratory Medicine, McGill University Health Centre, Montréal, Que.; Division of Infectious Diseases (Silverman), Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ont.; Division of Infectious Diseases (Tan), St. Michael’s Hospital, Toronto, Ont.; J.D. MacLean Centre for Tropical Diseases (Yansouni), Division of Infectious Diseases, Department of Medical Microbiology, McGill University Health Centre, McGill University, Montréal, Que.; Department of Internal Medicine (Zarychanski), Sections of Hematology and Medical Oncology, and Critical Care, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Division of Infectious Diseases (Murthy), Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC
MD MScRobert Fowler
MDCM MS
Ruxandra Pinto
PhD
Alain Tremblay
MDCM
Sergio Borgia
MSc MD
François M. Carrier
MD MSc
Matthew P. Cheng
MD SM
John Conly
MD
Cecilia T. Costiniuk
MD MSc
Peter Daley
MD MSc
Erick Duan
MD MSc
Madeleine Durand
MD MSc
Patricia S. Fontela
MD PhD
George Farjou
MD
Mike Fralick
MD PhD
Anna Geagea
MD
Jennifer Grant
MDCM
Yoav Keynan
MD PhD
Kosar Khwaja
MD MBA
Nelson Lee
MD MBBS
Todd C. Lee
MD MPH
Rachel Lim
MD
Conar R. O’Neil
MD MSc
Jesse Papenburg
MDCM MSc
Makeda Semret
MD
Michael Silverman
MD
Wendy Sligl
MD MSc
Ranjani Somayaji
MD MPH
Darrell H.S. Tan
MD PhD
Jennifer L.Y. Tsang
MD PhD
Jason Weatherald
MD MSc
Cedric Philippe Yansouni
MD
Ryan Zarychanski
MD MSc
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trial
Vincent I. Lau, Robert Fowler, Ruxandra Pinto, Alain Tremblay, Sergio Borgia, François M. Carrier, Matthew P. Cheng, John Conly, Cecilia T. Costiniuk, Peter Daley, Erick Duan, Madeleine Durand, Patricia S. Fontela, George Farjou, Mike Fralick, Anna Geagea, Jennifer Grant, Yoav Keynan, Kosar Khwaja, Nelson Lee, Todd C. Lee, Rachel Lim, Conar R. O’Neil, Jesse Papenburg, Makeda Semret, Michael Silverman, Wendy Sligl, Ranjani Somayaji, Darrell H.S. Tan, Jennifer L.Y. Tsang, Jason Weatherald, Cedric Philippe Yansouni, Ryan Zarychanski, Srinivas Murthy
Jul 2022, 10 (3) E807-E817; DOI: 10.9778/cmajo.20220077
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trial
Vincent I. Lau, Robert Fowler, Ruxandra Pinto, Alain Tremblay, Sergio Borgia, François M. Carrier, Matthew P. Cheng, John Conly, Cecilia T. Costiniuk, Peter Daley, Erick Duan, Madeleine Durand, Patricia S. Fontela, George Farjou, Mike Fralick, Anna Geagea, Jennifer Grant, Yoav Keynan, Kosar Khwaja, Nelson Lee, Todd C. Lee, Rachel Lim, Conar R. O’Neil, Jesse Papenburg, Makeda Semret, Michael Silverman, Wendy Sligl, Ranjani Somayaji, Darrell H.S. Tan, Jennifer L.Y. Tsang, Jason Weatherald, Cedric Philippe Yansouni, Ryan Zarychanski, Srinivas Murthy
Jul 2022, 10 (3) E807-E817; DOI: 10.9778/cmajo.20220077
Related Articles
Cited By...
- No citing articles found.